Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,909,896
+$10,321,845 QoQ
Shares Held
114,025
+9.6% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#70
of 503 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. AXSM ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in AXSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,909,896 | 114,025 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,588,051 | 104,059 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $18,888,261 | 103,418 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $14,410,769 | 118,656 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $13,342,814 | 127,817 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $6,806,874 | 58,363 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $3,233,031 | 38,211 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,441,047 | 27,162 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,033,298 | 12,836 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,256,423 | 28,276 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $662,984 | 8,330 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $682,196 | 9,761 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $841,265 | 11,707 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $544,326 | 8,825 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $669,257 | 8,677 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $525,846 | 11,785 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $218,156 | 5,696 | Shares | Defined | 2022-08-15 | |
| 2020-12-31 | $551,877 | 6,774 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $997,856 | 14,005 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,460,881 | 17,755 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,258,079 | 21,385 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||